Search

Brett E Thomes

age ~55

from Grandview, TX

Get Report
Also known as:
  • Brett Edwin Thomes
  • Brett E Thomas
  • Be Thomes
  • Edwin J Thomes
Related to:
Connected to:

Brett Thomes Phones & Addresses

  • Grandview, TX
  • 515 Crested Oak Ct, Fort Worth, TX 76108
  • Willow Park, TX
  • Aledo, TX
  • 1508 University Dr, Arlington, TX 76013 • 817 276-0008
  • 1703 Russwood Dr, Arlington, TX 76012 • 817 459-3409
  • 2304 Windsprint Way, Arlington, TX 76014
  • Parker, TX

Work

  • Company:
    Mentor worldwide llc
    May 1997 to Mar 2001
  • Position:
    Manufacturing engineer- senior engineer and superviser

Education

  • Degree:
    Doctorates, Doctor of Philosophy
  • School / High School:
    Ut Southwestern Medical Center
    2006 to 2006
  • Specialities:
    Biomedical Engineering, Bioengineering, Philosophy

Skills

Validation • Fda • Gmp • Medical Devices • Sop • 21 Cfr Part 11 • Clinical Trials • Regulatory Affairs • Product Launch • Clinical Development • Change Control • Capa • R&D • Cross Functional Team Leadership • Iso 13485 • Pharmaceutical Industry • U.s. Food and Drug Administration • Biotechnology

Industries

Pharmaceuticals

Us Patents

  • Ophthalmic Device Having Therapeutic Agent Delivery Capability And Method Of Forming Same

    view source
  • US Patent:
    20100016439, Jan 21, 2010
  • Filed:
    Jul 20, 2009
  • Appl. No.:
    12/505558
  • Inventors:
    Brett E. Thomes - Arlington TX, US
    Stephen J. Van Noy - Southlake TX, US
    Chi-Chun Tsai - Fort Worth TX, US
  • International Classification:
    A61K 47/14
    A61K 31/165
  • US Classification:
    514619, 514785
  • Abstract:
    The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

  • Intraocular Lenses With Interlenticular Opacification Resistance

    view source
  • US Patent:
    20110060408, Mar 10, 2011
  • Filed:
    Sep 2, 2010
  • Appl. No.:
    12/874863
  • Inventors:
    Chi-Chun Tsai - Fort Worth TX, US
    Brett E. Thomes - Arlington TX, US
    Stephen J. Van Noy - Southlake TX, US
  • International Classification:
    A61F 2/16
  • US Classification:
    623 632, 623 662
  • Abstract:
    The present invention is directed to an intraocular lens, an intraocular lens system and a method of producing and/or implanting the lens or system in an eye wherein at least one intraocular lens includes a coating that aids in resisting interlenticular opacification (ILO). The material of the coating is preferably hydrophilic or super-hydrophobic.

  • Intraocular Lenses With Interlenticular Opacification Resistance

    view source
  • US Patent:
    20120059466, Mar 8, 2012
  • Filed:
    Aug 2, 2011
  • Appl. No.:
    13/195883
  • Inventors:
    Chi-Chun Tsai - Fort Worth TX, US
    Brett E. Thomes - Arlington TX, US
    Stephen J. Van Noy - Southlake TX, US
    Atsmon Shahar - Cresson TX, US
  • International Classification:
    A61F 2/16
    B05D 7/00
  • US Classification:
    623 662, 427 224
  • Abstract:
    The present invention is directed to an intraocular lens, an intraocular lens system and a method of producing and/or implanting the lens or system in an eye wherein at least one intraocular lens includes a coating that aids in resisting opacification (e.g., posterior capsule opacification (PCO), interlenticular opacification (ILO) or the like). The material of the coating is preferably hydrophilic or super-hydrophobic.

  • Intraocular Lenses With Interlenticular Opacification Resistance

    view source
  • US Patent:
    20130282118, Oct 24, 2013
  • Filed:
    Jun 20, 2013
  • Appl. No.:
    13/922373
  • Inventors:
    - Basel, CH
    Brett Thomes - Arlington TX, US
    Stephen J. Van Noy - Southlake TX, US
  • International Classification:
    A61F 2/16
  • US Classification:
    623 634
  • Abstract:
    The present invention is directed to an intraocular lens, an intraocular lens system and a method of producing and/or implanting the lens or system in an eye wherein at least one intraocular lens includes a coating that aids in resisting interlenticular opacification (ILO). The material of the coating is preferably hydrophilic or super-hydrophobic.

Resumes

Brett Thomes Photo 1

Head Of Technology Transfer, Surgical Iol R And D

view source
Location:
Fort Worth, TX
Industry:
Pharmaceuticals
Work:
Mentor Worldwide Llc May 1997 - Mar 2001
Manufacturing Engineer- Senior Engineer and Superviser
Alcon, A Novartis Company May 1997 - Mar 2001
Head of Technology Transfer, Surgical Iol R and D
Education:
Ut Southwestern Medical Center 2006 - 2006
Doctorates, Doctor of Philosophy, Biomedical Engineering, Bioengineering, Philosophy The University of Texas at Arlington 1995 - 1998
Masters, Biomedical Engineering, Bioengineering Midwestern State University 1988 - 1992
Bachelors, Bachelor of Science, Chemistry
Skills:
Validation
Fda
Gmp
Medical Devices
Sop
21 Cfr Part 11
Clinical Trials
Regulatory Affairs
Product Launch
Clinical Development
Change Control
Capa
R&D
Cross Functional Team Leadership
Iso 13485
Pharmaceutical Industry
U.s. Food and Drug Administration
Biotechnology
Get Report for Brett E Thomes from Grandview, TX, age ~55
Control profile